These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31111543)

  • 1. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
    Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
    Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of DNA Flow Cytometric Analysis of Paraffin-embedded Tissue in the Risk Stratification and Management of 'Indefinite for dysplasia' in Patients With Inflammatory Bowel Disease.
    Wen KW; Rabinovitch PS; Wang D; Huang D; Mattis AN; Choi WT
    J Crohns Colitis; 2019 Mar; 13(4):472-481. PubMed ID: 30423034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
    J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
    Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
    Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
    Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
    Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
    Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
    Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
    Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and risk stratification of Barrett's dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue.
    Choi WT; Tsai JH; Rabinovitch PS; Small T; Huang D; Mattis AN; Kakar S
    Gut; 2018 Jul; 67(7):1229-1238. PubMed ID: 28642331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
    Montgomery E; Bronner MP; Goldblum JR; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Toledano AY; Shyr Y; Washington K
    Hum Pathol; 2001 Apr; 32(4):368-78. PubMed ID: 11331953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies.
    Lee H; Rabinovitch PS; Mattis AN; Kakar S; Choi WT
    Hum Pathol; 2020 May; 99():80-87. PubMed ID: 32272125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
    Dorer R; Odze RD
    Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T; Nair P; Dronfield MW; Mayberry JF
    Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
    B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
    Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
    van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
    J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of "indefinite for dysplasia" grading in Barrett metaplasia.
    Younes M; Lauwers GY; Ertan A; Ergun G; Verm R; Bridges M; Woods K; Meriano F; Schmulen C; Johnson C; Barroso A; Schwartz J; McKechnie J; Lechago J
    Arch Pathol Lab Med; 2011 Apr; 135(4):430-2. PubMed ID: 21466357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter-observer and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings.
    Allende D; Elmessiry M; Hao W; DaSilva G; Wexner SD; Bejarano P; Berho M; Al-Qadasi M
    Colorectal Dis; 2014 Sep; 16(9):710-8; discussion 718. PubMed ID: 24836541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
    Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
    Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.